Thus, the versatility of the GTωA pathway, together with suitable membrane transporters such as MCTs 1, 2, and 4, which are overexpressed in many cancers, provides a metabolic network to facilitate and channel amino acids and α-keto acids to appropriate organelles and compartments critical for energy production or biosynthetic pathways. Here, SLC16A1 is linked to cancer.